Hims & Hers Health Inc. buy geldnutzer
Start price
24.03.25
/
50%
€34.69
Target price
24.03.26
€44.00
Performance (%)
-8.62%
Price
12.12.25
€31.70
Summary
This prediction is currently active. With a performance of -8.62%, the BUY prediction for Hims & Hers Health Inc. by geldnutzer is down slightly. This prediction currently runs until 24.03.26. The prediction end date can be changed by geldnutzer at any time. geldnutzer has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hims & Hers Health Inc. | -5.851% | -5.851% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
According to geldnutzer what are the pros and cons of Hims & Hers Health Inc. for the foreseeable future?
Pros
EBIT growth >5% per year expected
Good rating
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Standard Investments for future growth
Future proof or reliable business model
Cons
Lower EBIT Margin than peer group
High valuation
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Sustainability is little important
high free float
Below average Marketposition
Significant cyclical dependencies
Revenue decline/stagnation expected
negative Cash Flow expected
Higher risks for its business
Unknown brand
Probably not worthwhile Investment
Very low/no dividend yield expected
Below average Management
Little innovation
Bad culture
Comments by geldnutzer for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Buy Hims & Hers Health Inc.
Kursziel gesetzt auf 39,0
Kursziel geändert auf 49,0
Kursziel geändert auf 54,0
Kursziel geändert auf 44,0
Stopped prediction by geldnutzer for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€28.33
21.01.25
21.01.25
€25.00
21.01.26
21.01.26
22.45%
24.03.25
24.03.25
EBIT growth >5% per year expected
Good rating
Lower EBIT Margin than peer group
High valuation
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€30.77
03.12.24
03.12.24
€37.00
03.12.25
03.12.25
-7.93%
21.01.25
21.01.25
EBIT growth >5% per year expected
Good rating
Lower EBIT Margin than peer group
High valuation


